Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374-82
Eur Urol. 2021 Sep;80(3):e77-e78.
doi: 10.1016/j.eururo.2021.06.003.
Epub 2021 Jun 12.
1 Department of Oncology, Division of Radiation Oncology, London Health Sciences Centre and Western University, London, Canada.
2 Departments of Medicine and Radiology, McMaster University, Hamilton, Canada.
3 Department of Oncology, Division of Radiation Oncology, London Health Sciences Centre and Western University, London, Canada. Electronic address: [email protected].